The FDA's pausing its onsite inspections may have had negative consequences for drug quality, according to an analysis in Health Affairs. The agency said more inspections are coming.
Share this post
New Study Finds FDA’s Inspection Pause May…
Share this post
The FDA's pausing its onsite inspections may have had negative consequences for drug quality, according to an analysis in Health Affairs. The agency said more inspections are coming.